Início › Câncer de Mama › Louisiana
Ensaios clínicos de Câncer de Mama em Louisiana
23 estudos para Câncer de Mama estão buscando participantes em locais em Louisiana.
Cidades em Louisiana
Texto oficial do estudo (Inglês)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Willis-Knighton Cancer Center, Shreveport
RecrutandoFase 3
Idades de 18 a 100 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Our Lady of the Lake Physician Group, Baton Rouge
- Our Lady of The Lake, Baton Rouge
- e mais 7
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- LSU Health Sciences Center, Shreveport
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07102381A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Ochsner Clinic Foundation ( Site 0021), New Orleans
- Louisiana State University Health Sciences Shreveport ( Site 0053), Shreveport
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06966700A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042), Baton Rouge
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06312176A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Baton Rouge
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06103864Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Willis Knighton Cancer Center, Shreveport
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07214532A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Our Lady of the Lake RMC, Baton Rouge
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07174336A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- University Medical Center-New Orleans, New Orleans
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT06492616A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- Ochsner Medical Center (OMC), New Orleans
RecrutandoFase 1
Idades de 18 a 55 · Mulheres · Atualizado em 9 de set. de 2026 · NCT07310420Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Abbeville General Hospital, Abbeville
- Louisiana Hematology Oncology Associates LLC, Baton Rouge
- Mary Bird Perkins Cancer Center - Covington, Covington
- e mais 7
RecrutandoFase 3
Idades de 18 a 60 · Mulheres · Atualizado em 2 de set. de 2026 · NCT05879926Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Care Access-Marrero, Marrero
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06072612A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Ochsner Clinic Foundation, Covington
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT06926868E-Mindfulness Approaches for Living After Breast Cancer
- University Medical Center New Orleans, New Orleans
RecrutandoFase 3
Idades de 18 a 50 · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT06748222First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Louisiana State University Health Sciences Center, New Orleans
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT05768139De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Louisiana State University Health Science Center, New Orleans
- University Medical Center New Orleans, New Orleans
- Ochsner Medical Center Jefferson, New Orleans
- e mais 2
RecrutandoFase 3
Idades de 50 a 70 · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT04852887Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Ochsner LSU Health Monroe Medical Center, Monroe
- LSU Health Sciences Center at Shreveport, Shreveport
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 17 de mar. de 2026 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Orleans
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- University Medical Center - New Orleans, New Orleans
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 10 de out. de 2025 · NCT06784193S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- LSU Health Baton Rouge-North Clinic, Baton Rouge
- Louisiana Hematology Oncology Associates LLC, Baton Rouge
- Mary Bird Perkins Cancer Center, Baton Rouge
- e mais 4
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de out. de 2025 · NCT03418961MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- Louisiana State University, Shreveport
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2025 · NCT03053193The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
- Pennington Biomedical Research Center, Baton Rouge
RecrutandoEstudo observacional
Idades 18 e acima · Mulheres · Atualizado em 17 de fev. de 2025 · NCT06318507CtDNA Based MRD Testing for NAC Monitoring in TNBC
- Louisiana State University, New Orleans
RecrutandoEstudo observacional
Idades 18 e acima · Mulheres · Atualizado em 7 de jan. de 2025 · NCT06230185Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.